ImmuneID is a series a startup based in United States. 1 investor tracked on Brouky Intelligence. Data sourced from Brouky Intelligence.
About
ImmuneID is a biotechnology company that has developed a platform to identify and therapeutically target antibody interactions that drive immune diseases.
Stage
series-a
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky